Vertex Pharmaceuticals VRTX Total CF product revenues, net — Total revenues

Other product segments

Similar metrics at other companies

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

GERNProduct revenue, net — Total revenues

$57.47M+17.3%

QTRXProduct revenue — Total revenues

$23.48M+39.5%

WHDProduct revenue — Total revenues

$297.24M+42.2%

KNTKProduct revenue — Total revenues

$312.23M-0.1%

GERNGross product revenue — Total revenues

$72.44M+25.2%

FAQ

What is Vertex Pharmaceuticals's total CF product revenues, net — total revenues?

Vertex Pharmaceuticals (VRTX) reported total CF product revenues, net — total revenues of $3.21B in Q2 2026.

What does total CF product revenues, net — total revenues mean?

This metric represents the aggregate net sales generated from the company's portfolio of cystic fibrosis therapeutic products. It serves as the primary revenue stream for the organization, reflecting the market adoption and commercial success of its core disease-modifying treatments. Monitoring this figure provides insight into the company's ability to maintain its standard-of-care position within the cystic fibrosis market.